Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

Background: Our previous study reported that histamine H2 receptor antagonists (H2RAs) exposure was associated with decreased mortality in critically ill patients with heart failure (HF) through the same pharmacological mechanism as β-blockers. However, population-based clinical study directly compa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xue-Sha Zhang, Wen-Ke Cai, Ping Wang, Ran Xu, Sun-Jun Yin, Yan-Hua Huang, Yu Guo, Fang-Fang Jiang, Jian-Mei Pan, Yi-Hua Li, Gong-Hao He
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-11-01
Colecção:	Frontiers in Pharmacology
Assuntos:	histamine H2 receptor antagonists β-blockers heart failure mortality medical information mart for intensive care
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1273640/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!